Latest Human papillomavirus Stories

Wartrol warts relief now uses the ingredients which have long been used to remove warts and administered by physicians and dermatologists. The powerful combinations of natural ingredients have made wartrol one of the fast acting formula. Los Angeles, CA (PRWEB) May 11, 2013 Warts removal formula by wartrol is well known to customers across the world due to its natural and fast acting formula against warts which can be used at home without consulting any doctor. To ensure the wartrol...

In recognition of National Teen Pregnancy Prevention Month, polyDNA recommends efforts to reduce unintended teen pregnancy and taking Gene-Eden-VIR against latent, STD viruses Rochester, NY (PRWEB) May 06, 2013 A new study published in the journal Pediatrics this month (1) says “most older teens (aged 17-19) are sexually active.” And, “Approximately 30% of those aged 15 to 16 have had sex.” These are important statistics since a Guttmacher.org report published in March of this...

polyDNA recommends Gene-Eden-VIR for people concerned about the relationship between asymptomatic HPV infection and lung cancer. Rochester, NY (PRWEB) April 21, 2013 Almost everyone knows that HPV can cause genital warts and even cervical cancer. As it turns out, new research shows that the same strains of HPV that can cause cervical cancer may also trigger lung cancer. (1) It is important to note that while cervical cancer has warning signs such as cervical displasia, lung cancer often...

Significant benefit also seen in men The proportion of young women diagnosed with genital warts in Australia has seen a significant decline thanks to the HPV vaccine, suggests a paper published today on bmj.com. In 2007, Australia became one of the first countries to implement a nationally funded quadrivalent human papillomarivus (HPV) vaccination programme for girls and young women, which offers free vaccinations to girls aged 12-13 years in schools. From 2007 – 2009 there were a...

Biotech recognized for VGX-3100, an innovative therapy for pre-cancers and cancers caused by HPV, now in phase II for cervical dysplasia BLUE BELL, Pa., April 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was presented Vaccine Industry Excellence (ViE) Awards for "Best Therapeutic Vaccine" and "Best Early Stage Biotech" at the World Vaccine Congress, which is being held this week in Washington, D.C. The ViE Awards recognize outstanding...

Throat cancers on the rise due to epidemic of HPV infection TORONTO, April 17, 2013 /CNW/ - Researchers in London, Ontario, are conducting a first-ever clinical trial to determine which treatment option gives patients with throat cancers the best quality of life. These cancers are dramatically on the rise due to the epidemic of HPV (human papilloma virus) infection. Surgeon Dr Anthony Nichols and radiation oncologist Dr David Palma at the Lawson Research Centre have received a...

Certain types of papilloma virus might actually prevent cervical cancer, according to a new study by researchers from The University of Manchester. There are over 100 different types of human papilloma virus (HPV). Cervical cancer is known to be caused by infection with approximately 14 so-called “high-risk” types of this virus. Researchers from Manchester looked at the different types of HPV found in cervical smears and invasive cervical cancers from HIV positive and HIV negative...

Medical centers throughout U.S. will take part in 16th Annual OHANCAW®, April 14 - 20 NEW YORK, April 10, 2013 /PRNewswire/ -- The Head and Neck Cancer Alliance (HNCA) today urged Americans to get screened for cancer by unveiling the Grand Prize winner and Runners-Up in the Oral, Head and Neck Cancer Awareness Week® (OHANCAW®) national video contest. The OHANCAW Challenge was developed to engage young adults in educating the public about the signs, symptoms and risk factors of...

Oral Cancer Screenings for the public, April 17, 2013 4:00pm-until all patients are seen. Beaumont, TX (PRWEB) April 01, 2013 Gulfside Dental is providing free visual head and neck oral cancer exams on April 17th to educate Southeast Texas on the importance of early screening and detection in oral cancers. While all Gulfside Dental patients receive visual oral cancer screenings during regular visits, April is recognized as Oral Cancer Awareness Month by the Oral Cancer Foundation and...

SAN DIEGO, April 1, 2013 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today reported its financial results for the three months and the year ended December 31, 2012. (Logo: http://photos.prnewswire.com/prnh/20120620/LA28014LOGO) Fourth Quarter 2012 Financial Results For the fourth quarter ended December 31, 2012, Trovagene reported a net loss of $6.3 million, or $0.43 per share, as compared to a net loss of $1.3 million, or $0.12...